• Search MS Observer

   

• Categories

  • News
  • Personal Stories
  • Research
  • Work & Disability

• Recent Comments

  • larry scheler on Saving Grace: Device gives walking help to those with disorders
  • larry scheler on Saving Grace: Device gives walking help to those with disorders
  • Trisha Ramos on Stem Cell Tourists Denied: Costa Rica Stops Treatments at Top Clinic
  • Lily on Stem Cell Tourists Denied: Costa Rica Stops Treatments at Top Clinic
  • terry poole on Leukaemia drug can halt, reverse MS

• Recent Posts

  • Multiple Sclerosis Changes With the Seasons
  • MS Patient, Singer Gives to Others – WSJ.com
  • Multiple sclerosis theory dealt a blow by studies – Los Angeles Times
  • Doc calls costly therapy ‘robbery’
  • Stem Cell Tourists Denied: Costa Rica Stops Treatments at Top Clinic
  • Vitamin D Linked to Poor Learning Performance in Patients With MS
  • O’Jays Singer Reveals Long Battle With Multiple Sclerosis
  • Liberation or placebo effect?
  • Twin Study Deepens Multiple Sclerosis Mystery
  • UV Radiation, Not Vitamin D, Might Limit Multiple Sclerosis Symptoms
  • Discovery May Lead to Better Multiple Sclerosis Treatments – BusinessWeek
  • Learning to Trust Myself
  • Online Social Networks Bridge Gaps for Chronically Ill
  • Testing new MS theory as patients demand care now
  • Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis

• Archives

  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008

•  

   

   

   

ScienceDaily July 21, 2008 — The CUPID Cannabinoid Use in Progressive Inflammatory brain Disease study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis MS has been recruited to the study.

CUPID is a clinical trial which will evaluate whether tetrahydrocannabinol THC, one of many compounds found in the in the cannabis plant and the main active ingredient is able to slow the progression of MS.

This is an important study for people with MS because current treatments either target the immune system in the early stages of MS, or are aimed at easing specific symptoms such as muscle spasms or bladder problems. At present there is no treatment which slows progression of the disease.

read the rest:  Can Cannabis Compounds Slow The Progression Of Multiple Sclerosis?

Comments

• Blogroll

  • Mayo Clinic – Multiple Sclerosis
  • National Multiple Sclerosis Society
  • This is MS
  • Wikipedia on MS

• Communities

  • Living with Multiple Sclerosis
  • MS World Forums
  • Patients Like Me

• Resources

  • Living with Multiple Sclerosis
  • MS World
  • Patients Like Me
  • Understanding Multiple Sclerosis

•  

   

   

   

•  

   

   

• Important Notice

  This site posts excerpts and summaries of articles of interest to people with multiple sclerosis and their families, along with links to the full articles in the journals in which they were published.

  I have multiple sclerosis (primary progressive), but I am neither a doctor nor a research scientist. I have no connection to the people mentioned in these articles, and have no more information about the subject of any given article than is contained in the article itself. Please do not ask me for medical advice or how to contact people mentioned in these articles. If contact information is not contained in the article itself, your best bet is to Google the name of the person, company or clinic you are seeking.